Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Oxford Nanopore Technologies PLC ( (GB:ONT) ).
Oxford Nanopore Technologies has issued 52,182 new ordinary shares to Chief Executive Officer Francis Van Parys as part of its Long Term Incentive Plan 2021, following the vesting of awards on 3 March 2026. The shares, issued at nil cost and admitted on the London Stock Exchange, reflect the company’s use of equity-based remuneration to align executive incentives with long-term shareholder value and corporate performance.
The transaction underscores the continued reliance on performance-linked share awards to retain and reward key leadership at a critical stage of Oxford Nanopore’s growth in the competitive genomics sector. For investors, the modest increase in share capital is unlikely to be materially dilutive but signals ongoing commitment to incentive structures designed to support strategic execution and market positioning.
The most recent analyst rating on (GB:ONT) stock is a Hold with a £108.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Spark’s Take on GB:ONT Stock
According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.
The score is held back primarily by weak financial performance—large ongoing losses and continued cash burn—despite improving revenue growth and solid gross margins. Technicals also detract due to a clear downtrend (below major moving averages and negative MACD). Offsetting factors include constructive earnings-call guidance with margin/OpEx discipline and a credible longer-term breakeven timeline, plus a relatively low-leverage balance sheet.
To see Spark’s full report on GB:ONT stock, click here.
More about Oxford Nanopore Technologies PLC
Oxford Nanopore Technologies plc operates in the biotechnology and genomics industry, developing and commercialising nanopore-based DNA and RNA sequencing technologies. Its products are used in scientific research, clinical and industrial applications, with a focus on providing scalable, real-time sequencing solutions to laboratories and healthcare-related customers worldwide.
Average Trading Volume: 1,688,523
Technical Sentiment Signal: Strong Sell
Current Market Cap: £1.18B
For an in-depth examination of ONT stock, go to TipRanks’ Overview page.